Advantage Investment Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $34K | Sell |
342
-90
| -21% | -$8.95K | 0.03% | 411 |
|
|
2019
Q2 | $47K | Sell |
432
-210
| -33% | -$22.8K | 0.04% | 356 |
|
|
2019
Q1 | $72K | Hold |
642
| – | – | 0.06% | 278 |
|
|
2018
Q4 | $62K | Hold |
642
| – | – | 0.05% | 306 |
|
|
2018
Q3 | $78K | Sell |
642
-93
| -13% | -$11.3K | 0.05% | 318 |
|
|
2018
Q2 | $81K | Hold |
735
| – | – | 0.06% | 287 |
|
|
2018
Q1 | $78K | Sell |
735
-66
| -8% | -$7K | 0.03% | 315 |
|
|
2017
Q4 | $86K | Hold |
801
| – | – | 0.03% | 316 |
|
|
2017
Q3 | $89K | Hold |
801
| – | – | 0.03% | 277 |
|
|
2017
Q2 | $83K | Sell |
801
-66
| -8% | -$6.84K | 0.03% | 265 |
|
|
2017
Q1 | $85K | Sell |
867
-1,539
| -64% | -$151K | 0.03% | 249 |
|
|
2016
Q4 | $213K | Buy |
2,406
+1,641
| +215% | +$145K | 0.08% | 142 |
|
|
2016
Q3 | $74K | Sell |
765
-90
| -11% | -$8.71K | 0.03% | 262 |
|
|
2016
Q2 | $73K | Sell |
855
-2,400
| -74% | -$205K | 0.03% | 284 |
|
|
2016
Q1 | $283K | Buy |
3,255
+2,475
| +317% | +$215K | 0.12% | 106 |
|
|
2015
Q4 | $88K | Sell |
780
-60
| -7% | -$6.77K | 0.05% | 252 |
|
|
2015
Q3 | $85K | Sell |
840
-15
| -2% | -$1.52K | 0.05% | 240 |
|
|
2015
Q2 | $105K | Buy |
855
+192
| +29% | +$23.6K | 0.05% | 234 |
|
|
2015
Q1 | $76K | Buy |
663
+438
| +195% | +$50.2K | 0.04% | 278 |
|
|
2014
Q4 | $23K | Buy |
+225
| New | +$23K | 0.02% | 404 |
|